JORDAN BROWN: Open Payments
NPI 1346500998 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$723 in 31 payments from 8 companies in 2025. Trend: 2023 $1,604 · 2024 $1,048 · 2025 $723
Food & beverage: $723
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $233 |
| E.R. Squibb & Sons, L.L.C. | 5 | $185 |
| Teva Pharmaceuticals USA, Inc. | 5 | $99 |
| Alkermes, Inc. | 4 | $87 |
| LivaNova USA, Inc. | 1 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Noven Therapeutics, LLC | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
Products named: VRAYLAR, COBENFY, AUSTEDO XR, ARISTADA, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, TRINTELLIX, Xelstrym, CAPLYTA.
Industry payments across FL — which companies pay providers there.
